YH239-EE is a potent p53-MDM2 antagonist and apoptosis inducer; it inhibits the p53-MDM2 interaction, leading to growth inhibition in OCI-AML-3 cells and other acute myeloid leukemia (AML) cells with wild-type p53; it induces cell cycle arrest and robust apoptosis by activating p53 and its downstream targets in AML cells, including p53 wild-type (OCI-AML-3 and MOLM-13), p53-mutant (NB4), and p53-null (HL60) cell lines.